Sun Pharma Q4 earnings came in line with street estimates. The company reported a profit in Q4 of Rs 1,984 crore, as against a loss of Rs 2,277 crore a year earlier. The company's EBITDA also rose by 30% to Rs 2,829 crore as compared with a forecast of Rs 2,993 crore. The stock was trading higher by 1.46 per cent after the results were announced earlier today.
